Skip to main content

Month: February 2021

Protech Enters Florida With Accretive Acquisition of Mayhugh’s Medical Equipment

$7 Million in Annualized Revenues, in Excess of 15% Adjusted EBITDA Margin and Increases Protech’s Active Patient Count by More Than 10,0005,000 Patients to Immediately Enter Protech’s Subscription Re-Supply PlatformCINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) — Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: PTQ), (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that it has acquired Mayhugh’s Medical Equipment (“MME”), a company based in Florida, reporting unaudited trailing 12-month annual revenues of approximately $7 million, Adjusted EBITDA (defined below) of $1.2 million, and positive net income.Acquisition DetailsExcluding the impact of future acquisitions, and organic growth derived from continuing operations, we are pleased...

Continue reading

Recruiter.com Acquires Scouted.io, a Video-based Candidate Insight Platform

HOUSTON, Feb. 02, 2021 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB: RCRT), an on-demand video-enabled and artificial intelligence hiring platform with the world’s largest network of recruiters, today announced that it acquired Scouted.io, a venture capital-backed tech startup focused on unlocking human potential by developing deep insights into candidates using video screening and AI-based scoring algorithms.Recruiter.com’s purchase of Scouted was successfully closed on 1/31/21 through an asset purchase agreement. Recruiter.com paid for the acquisition primarily in restricted common stock.“Using video and deep candidate profiling, Scouted understands more about its talent ecosystem than any other system that I have encountered,” said Evan Sohn, CEO of Recruiter.com. “We are excited to add Scouted’s...

Continue reading

Oncocyte Announces Definitive Agreement to Acquire Chronix Biomedical, Inc.

Transaction includes proprietary IP and technology for blood-based immune therapy monitoring and for transplant rejection testingNovel, patented copy number index (CNI) therapy monitoring test developed by Chronix complements Oncocyte’s proprietary DetermaIO™ test for immunotherapy treatment selection and may significantly expand the market opportunity for the CompanyIRVINE, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has entered into an agreement to acquire, through a subsidiary, Chronix Biomedical, a privately held molecular diagnostics company developing blood tests for use in cancer treatment and organ transplants. Under the...

Continue reading

Financial Institutions, Inc. Announces Completion of Landmark Group Acquisition

– Rochester, New York Insurance brokerage firm was acquired by SDN Insurance Agency, Financial Institutions’ insurance subsidiary– Kelly M. Shea and Christopher K. Shea will lead Rochester insurance operationsWARSAW, N.Y., Feb. 02, 2021 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), parent company of Five Star Bank (the “Bank”), SDN Insurance Agency, LLC (“SDN”), Courier Capital, LLC (“Courier Capital”) and HNP Capital, LLC (“HNP Capital”), announced that the acquisition of assets of Landmark Group (“Landmark”) by the Company’s insurance subsidiary SDN was completed on February 1, 2021.A staple of the Rochester community since 1984, Landmark was an independent insurance brokerage firm delivering insurance, surety and risk management solutions across many business sectors including construction, manufacturing,...

Continue reading

Full House Resorts Announces Proposed Offering of Senior Secured Notes

LAS VEGAS, Feb. 02, 2021 (GLOBE NEWSWIRE) — Full House Resorts, Inc. (Nasdaq: FLL) today announced that it intends, subject to market and other conditions, to offer $300 million in aggregate principal amount of senior secured notes due 2028 (the “Notes”) in a private debt offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be senior secured obligations of the Company and will be guaranteed, jointly and severally, by all of its current subsidiaries and future restricted subsidiaries.The Company intends to use the net proceeds from the offering (i) to redeem all of its outstanding senior secured notes due 2024, which had $106.8 million outstanding as of December 31, 2020, at a redemption price equal to 100.9% plus all accrued and unpaid interest...

Continue reading

PGS ASA: UK Scheme of Arrangement Approved by Court

February 2, 2021: Oslo, Norway, PGS ASA (the “Company” or “PGS”) announces that the UK Scheme of Arrangement (the “Scheme”) announced on November 26, 2020 in connection with the proposed amendments under its term loan B and revolving credit facilities (“TLB” and “RCF”, respectively) announced on October 21, 2020 (the “Transaction”), was approved by the High Court of Justice of England and Wales on February 2, 2021.The Scheme was approved following the approval of the Transaction at the preceding creditors’ meeting. The Scheme had support of lenders to the RCF/TLB facilities representing 95.3% by value of debt and 99.5% by number of creditors voting.The Court’s approval will enable the implementation of the Transaction, which will bind all TLB and RCF lenders. The final implementation of the Transaction is subject to customary conditions...

Continue reading

Brookfield Infrastructure Announces Sale of North American District Energy Business for $4.1 Billion

BROOKFIELD, News, Feb. 02, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure (NYSE: BIP; TSX: BIP.UN) today announced that it has signed definitive agreements to sell 100% of its North American district energy business, Enwave. The business will be divested through two separate transactions for total consideration of $4.1 billion on an enterprise value basis. Ontario Teachers’ Pension Plan Board and IFM Investors have agreed to acquire 100% of Enwave’s Canadian business. Concurrently, QIC and Ullico have agreed to acquire 100% of Enwave’s U.S. business. Net proceeds to BIP are expected to be approximately $950 million.“The sale of Enwave caps off a hugely successful investment for Brookfield Infrastructure, one in which we grew the business significantly through organic growth initiatives and follow-on acquisitions,” said Sam Pollock,...

Continue reading

Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic Bacterial Vaccine Against COVID-19 Through Exclusive Option Agreement with Julius-Maximilians-University Wuerzburg

– Company secures next step to continue to build-out pipeline of assets– University researchers developed a proprietary and orally active bacterial vaccine platform technology currently undergoing pre-clinical studies for the prevention of coronavirus diseases, including COVID-19– Aeterna Zentaris to evaluate the University’s coronavirus vaccine platform technology including COVID-19 under an exclusive option agreementCHARLESTON, S.C., Feb. 02, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), through its wholly-owned subsidiary Aeterna Zentaris GmbH, (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the Company has entered into an exclusive option agreement to evaluate a preclinical...

Continue reading

Hubbell Reports Fourth Quarter and Full Year 2020 Results

Shelton, CT, Feb. 02, 2021 (GLOBE NEWSWIRE) — Exhibit 99.1HUBBELL REPORTS FOURTH QUARTER 2020 ANDFULL YEAR RESULTSQ4 diluted EPS of $1.48; adjusted diluted EPS of $1.76Q4 net sales decreased 6% (organic -7%, Acquisitions +1%)Closed three accretive bolt-on acquisitions in the fourth quarterFull Year 2020 diluted EPS of $6.43; adjusted diluted EPS of $7.58Includes restructuring and related investment ($0.43)Full Year 2020 free cash flow of $560 millionFY21 diluted EPS expected range of $6.95-$7.35; adjusted diluted EPS of $8.10-$8.50SHELTON, CT. (February 2, 2021) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter ended December 31, 2020.“Hubbell’s full year 2020 results demonstrate a strong year of operating performance and consistent execution,” said Gerben Bakker, President...

Continue reading

APPlife Digital Solutions, Inc. Signs LOI to Provide Global Marketing & Distribution Platform for Hemp and CBD Products

SAN FRANCISCO, Feb. 02, 2021 (GLOBE NEWSWIRE) — APPlife Digital Solutions, Inc. (OTCQB: ALDS) (“APPlife”, the Company”), a business incubator and portfolio manager that invests in and creates e-commerce and cloud-based solutions announced today that it has signed a Letter of Intent (“LOI”) with a privately-held company providing it with a world-wide, non-exclusive license for the purposes of utilizing APPlife’s all-inclusive, custom e-commerce platform to create a wholesale and retail marketplace to sell and distribute hemp based products, CBD and other related B2B and B2C products.The terms include equity, revenue sharing, and upon reaching future revenue benchmarks, additional equity allowing APPlife Digital a majority position. The specific terms of the LOI, including further investment details of the public venture partnership,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.